🇺🇸 FDA
Company

Compass

Compass Therapeutics

CMPX biotech USA

Quick answer

Compass is a biotech company (CMPX) headquartered in BOSTON, MA, USA with 15 tracked pipeline programs.

Pipeline (15)

project

COMP360 psilocybin

PTSD - Post Traumatic Stress Disorder

Phase 3 · small_molecule · active

1 trials project

CTX-009

Biliary Tract Cancer

Phase 3 · small_molecule · active

1 trials project

Psilocybin

Treatment Resistant Depression

Phase 3 · small_molecule · active

7 trials project

Psilocybin

Major Depressive Disorder

Phase 3 · small_molecule · active

2 trials project

CTX-009

Metastatic Colorectal Cancer

Phase 2 · small_molecule · completed

1 trials project

CTX-009

Glioblastoma

Phase 2 · small_molecule · active

1 trials project

CTX-009 (ABL001)

P1b: Advanced Solid Tumors

Phase 2 · small_molecule · terminated

1 trials project

Gemcitabine

Metastatic Biliary Tract Cancer

Phase 2 · small_molecule · active

1 trials project

Psilocybin

Treatment-Resistant Major Depressive Disorder

Phase 2 · small_molecule · terminated

1 trials project

Psilocybin

Anorexia Nervosa

Phase 2 · small_molecule · completed

2 trials project

Psilocybin

Body Dysmorphic Disorders

Phase 2 · small_molecule · completed

1 trials project

Psilocybin

Post Traumatic Stress Disorder

Phase 2 · small_molecule · completed

1 trials project

CTX-10726

Gastroesophageal Cancer (GC)

Phase 1 · small_molecule · active

1 trials project

CTX-471

Locally Advanced Solid Tumor

Phase 1 · small_molecule · completed

1 trials project

CTX-8371

Non Small Cell Lung Cancer

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12377112

Methods of treating neurocognitive disorders, chronic pain and reducing inflamma

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12312375

Preparation of psilocybin, different polymorphic forms, intermediates, formulati

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12286483

Method of treating cancer using CD137 antibodies and PD-1 antagonists

Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12186285

Compositions and methods of treatment for tinea pedis

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12070594

Biomedical electrode with anti-microbial properties

Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11970538

Multispecific binding constructs against checkpoint molecules and uses thereof

Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11939346

Preparation of psilocybin, different polymorphic forms, intermediates, formulati

Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11865179

Progesterone formulations having a desirable PK profile

Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)